Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rTMS and Botox in Spastic Diplegic Cerebral Palsy
NCT06218316Completed
- Sponsor
- Modern University for Technology and Information
- Start
- Oct 2023
- Primary completion
- Jan 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of botulinum toxin type A in cerebral palsy (CP) (3 arms), sponsored by Modern University for Technology and Information. Primary endpoint: Modified Ashworth Scale at 3 months. Started Oct 2023; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
cerebral palsy (CP)
Beyond the preview
Go deeper on NCT06218316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06218316.